Compounds containing matrix metalloproteinase substrates and methods of their use

Details for Australian Patent Application No. 2004270200 (hide)

Owner Bristol-Myers Squibb Company

Inventors Harris, Thomas D.; Yalamanchili, Padmaja

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004270200

PCT Pub. Number WO2005/023314

Priority 60/499,966 03.09.03 US; 60/499,960 03.09.03 US

Filing date 2 September 2004

Wipo publication date 17 March 2005

International Classifications

A61K 49/00 (2006.01) Preparations for testing

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023314 Priority application(s): WO2005/023314

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270201-Treatment for CD5+ B cell lymphoma

2004270190-Bone plate with captive clips